Krenciute G - Search Results

1

Synapse-tuned CARs enhance immune cell anti-tumor activity.

Chockley PJ, Ibanez-Vega J, Krenciute G, Talbot LJ, Gottschalk S. Chockley PJ, et al. Among authors: krenciute g. Nat Biotechnol. 2023 Oct;41(10):1434-1445. doi: 10.1038/s41587-022-01650-2. Epub 2023 Feb 2. Nat Biotechnol. 2023. PMID: 36732477

2

Analysis of the human endogenous coregulator complexome.

Malovannaya A, Lanz RB, Jung SY, Bulynko Y, Le NT, Chan DW, Ding C, Shi Y, Yucer N, Krenciute G, Kim BJ, Li C, Chen R, Li W, Wang Y, O'Malley BW, Qin J. Malovannaya A, et al. Among authors: krenciute g. Cell. 2011 May 27;145(5):787-99. doi: 10.1016/j.cell.2011.05.006. Cell. 2011. PMID: 21620140 Free PMC article.

3

What is the Optimal Design-Build-Test Cycle for Clinically Relevant Synthetic CAR T Cell Therapies?

Chen YY, Lim W, Levings M, Blazar B, Krenciute G, Wong W, Lehner M. Chen YY, et al. Among authors: krenciute g. Cell Syst. 2020 Sep 23;11(3):212-214. doi: 10.1016/j.cels.2020.08.017. Cell Syst. 2020. PMID: 32970992 Free PMC article. No abstract available.

4

Nuclear BAG6-UBL4A-GET4 complex mediates DNA damage signaling and cell death.

Krenciute G, Liu S, Yucer N, Shi Y, Ortiz P, Liu Q, Kim BJ, Odejimi AO, Leng M, Qin J, Wang Y. Krenciute G, et al. J Biol Chem. 2013 Jul 12;288(28):20547-57. doi: 10.1074/jbc.M112.443416. Epub 2013 May 30. J Biol Chem. 2013. PMID: 23723067 Free PMC article.

5

Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Rα2-positive Glioma.

Krenciute G, Krebs S, Torres D, Wu MF, Liu H, Dotti G, Li XN, Lesniak MS, Balyasnikova IV, Gottschalk S. Krenciute G, et al. Mol Ther. 2016 Feb;24(2):354-363. doi: 10.1038/mt.2015.199. Epub 2015 Oct 30. Mol Ther. 2016. PMID: 26514825 Free PMC article.

6

Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants.

Krenciute G, Prinzing BL, Yi Z, Wu MF, Liu H, Dotti G, Balyasnikova IV, Gottschalk S. Krenciute G, et al. Cancer Immunol Res. 2017 Jul;5(7):571-581. doi: 10.1158/2326-6066.CIR-16-0376. Epub 2017 May 26. Cancer Immunol Res. 2017. PMID: 28550091 Free PMC article.

7

Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models.

Mata M, Gerken C, Nguyen P, Krenciute G, Spencer DM, Gottschalk S. Mata M, et al. Among authors: krenciute g. Cancer Discov. 2017 Nov;7(11):1306-1319. doi: 10.1158/2159-8290.CD-17-0263. Epub 2017 Aug 11. Cancer Discov. 2017. PMID: 28801306 Free PMC article.

8

Adoptive Transfer of IL13Rα2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma.

Pituch KC, Miska J, Krenciute G, Panek WK, Li G, Rodriguez-Cruz T, Wu M, Han Y, Lesniak MS, Gottschalk S, Balyasnikova IV. Pituch KC, et al. Among authors: krenciute g. Mol Ther. 2018 Apr 4;26(4):986-995. doi: 10.1016/j.ymthe.2018.02.001. Epub 2018 Feb 8. Mol Ther. 2018. PMID: 29503195 Free PMC article.

9

CAR T-cell therapy for glioblastoma: ready for the next round of clinical testing?

Prinzing BL, Gottschalk SM, Krenciute G. Prinzing BL, et al. Among authors: krenciute g. Expert Rev Anticancer Ther. 2018 May;18(5):451-461. doi: 10.1080/14737140.2018.1451749. Epub 2018 Mar 16. Expert Rev Anticancer Ther. 2018. PMID: 29533108 Free PMC article. Review.

10

Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma.

Yi Z, Prinzing BL, Cao F, Gottschalk S, Krenciute G. Yi Z, et al. Among authors: krenciute g. Mol Ther Methods Clin Dev. 2018 Feb 2;9:70-80. doi: 10.1016/j.omtm.2018.01.009. eCollection 2018 Jun 15. Mol Ther Methods Clin Dev. 2018. PMID: 29552579 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page